Evidence map›Paper›PMID 38765009›Full record

ArticleFrontiers in immunology2024

A murine model of post-acute neurological sequelae following SARS-CoV-2 variant infection.

Ankita Singh, Awadalkareem Adam, Aditi, Bi-Hung Peng, Xiaoying Yu, Jing Zou, Vikram V Kulkarni, Peter Kan, Wei Jiang, Pei-Yong Shi and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mechanisms of sex differences in acute and long COVID sequelae in mice.bioRxiv : the preprint server for biology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Translating insights into therapies for Long Covid.Science translational medicine · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Ankita Singh *Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
Awadalkareem Adam *Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
AditiDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
Bi-Hung PengDepartment of Neuroscience, Cell Biology and Anatomy, University of Texas Medical Branch, Galveston, TX, United States.
Xiaoying YuDepartment of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston, TX, United States.
Jing ZouDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, United States.
Vikram V KulkarniDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
Peter KanDepartment of Neurosurgery, University of Texas Medical Branch, Galveston, TX, United States.
Wei JiangDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States.
Pei-Yong ShiDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, United States.
Parimal SamirDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
Irma CisnerosDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
Tian WangDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.

Funding

Revolutionary Eilat-based Chikungunya Vaccine VectorR01AI127744 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN · 2017 to 2021
$3.5M
Porous silicon microparticle-based subunit vaccines for SARS-CoV-2R01AI176670 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Tian Wang · 2023 to 2026
$2.7M
Role of microglia in neural infectionR01NS125778 · NINDS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Tian Wang, Ping Wu · 2022 to 2026
$2.5M
NIAID NIH HHS R01 AI127744NIAID NIH HHS R01 AI176670NINDS NIH HHS R01 NS125778
6 · The paper itself

Abstract

Viral variant is one known risk factor associated with post-acute sequelae of COVID-19 (PASC), yet the pathogenesis is largely unknown. Here, we studied SARS-CoV-2 Delta variant-induced PASC in K18-hACE2 mice. The virus replicated productively, induced robust inflammatory responses in lung and brain tissues, and caused weight loss and mortality during the acute infection. Longitudinal behavior studies in surviving mice up to 4 months post-acute infection revealed persistent abnormalities in neuropsychiatric state and motor behaviors, while reflex and sensory functions recovered over time. In the brain, no detectable viral RNA and minimal residential immune cell activation was observed in the surviving mice post-acute infection. Transcriptome analysis revealed persistent activation of immune pathways, including humoral responses, complement, and phagocytosis, and gene expression levels associated with ataxia telangiectasia, impaired cognitive function and memory recall, and neuronal dysfunction and degeneration. Furthermore, surviving mice maintained potent systemic T helper 1 prone cellular immune responses and strong sera neutralizing antibodies against Delta and Omicron variants months post-acute infection. Overall, our findings suggest that infection in K18-hACE2 mice recapitulates the persistent clinical symptoms reported in long-COVID patients and provides new insights into the role of systemic and brain residential immune factors in PASC pathogenesis.

Indexed as

COVID-19Disease Models, AnimalPost-Acute COVID-19 SyndromeSARS-CoV-2Angiotensin-Converting Enzyme 2AnimalsAntibodies, NeutralizingAntibodies, ViralBrainFemaleHumansMiceAngiotensin-Converting Enzyme 2Antibodies, NeutralizingAntibodies, ViralCNS inflammationinflammatory responseslong COVIDpost-acute sequelaeSARS-CoV-2 variant

Identifiers

PMID38765009
PMCPMC11099216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.